Poster Session Date, Time, and Location: Saturday, July 12, 2025, from 12:15-1:45 p.m. PT in the ENDO Expo Poster Area Rapid Fire Oral Presentation and Poster Title: Reduction in Rate of Hypoglycemic ...
- Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA Breakthrough Therapy designation, underway in post-bariatric hypoglycemia; completion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results